NCT07731646

Brief Summary

This study compared two anesthesia approaches for shoulder manipulation in adults with primary frozen shoulder that had not improved after at least 6 months of conservative treatment. A total of 72 participants were randomly assigned to undergo manipulation either with ultrasound-guided wide-awake local anesthesia no tourniquet (WALANT) in an outpatient setting or under general anesthesia in the operating room. The main outcome was shoulder forward flexion 4 weeks after the procedure. Other outcomes included shoulder abduction, external rotation, internal rotation, pain, shoulder function, anxiety before the procedure, and early procedure-related complications. Participants were evaluated before the procedure and during the first 4 weeks after treatment. The study aimed to determine whether outpatient manipulation under WALANT could provide short-term clinical outcomes comparable to those of manipulation under general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 24, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2025

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 23, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 28, 2026

Completed
Last Updated

July 29, 2026

Status Verified

July 1, 2026

Enrollment Period

6 months

First QC Date

July 23, 2026

Last Update Submit

July 27, 2026

Conditions

Keywords

Adhesive capsulitisfrozen shouldermanipulationWALANTgeneral anesthesiaoutpatient procedureshoulder range of motion

Outcome Measures

Primary Outcomes (1)

  • Mean Shoulder Forward Flexion at 4 Weeks

    Shoulder forward flexion was measured in degrees using a goniometer. Higher values indicate greater shoulder range of motion. The mean forward flexion value was compared between the two study arms.

    4 weeks after the procedure

Secondary Outcomes (10)

  • Mean Shoulder Abduction

    Baseline and 1, 2, 3, and 4 weeks after the procedure

  • Mean Shoulder External Rotation

    Baseline and 1, 2, 3, and 4 weeks after the procedure

  • Distribution of Shoulder Internal Rotation Categories

    Baseline and 1, 2, 3, and 4 weeks after the procedure

  • Mean Visual Analog Scale Pain Score

    Baseline and 1, 2, 3, and 4 weeks after the procedure

  • Mean Modified UCLA Shoulder Score

    Baseline and 1, 2, 3, and 4 weeks after the procedure

  • +5 more secondary outcomes

Study Arms (2)

Ultrasound-Guided WALANT-Based Manipulation

EXPERIMENTAL

Participants received ultrasound-guided administration of a 25-mL WALANT solution containing 12 mL of 2% lidocaine, 0.5 mL of 1:1,000 epinephrine, 2.5 mL of 8.4% sodium bicarbonate, and 10 mL of 0.9% sodium chloride into the glenohumeral joint, anterior capsule, and coracohumeral ligament region. After a 30-minute waiting period, standardized shoulder manipulation was performed in an outpatient setting.

Procedure: Ultrasound-Guided WALANT-Based Shoulder Manipulation

Manipulation Under General Anesthesia

ACTIVE COMPARATOR

Participants underwent standard preoperative preparation and shoulder manipulation in the operating room. General anesthesia was induced with intravenous propofol with mask ventilation provided throughout the procedure. The same standardized shoulder manipulation sequence was used as in the WALANT group.

Procedure: Shoulder Manipulation Under General Anesthesia

Interventions

Ultrasound-guided administration of a 25-mL WALANT solution followed by standardized shoulder manipulation after a 30-minute waiting period in an outpatient setting.

Ultrasound-Guided WALANT-Based Manipulation

Standardized shoulder manipulation performed in the operating room under general anesthesia induced with intravenous propofol.

Manipulation Under General Anesthesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or older.
  • Diagnosis of primary frozen shoulder.
  • Persistent symptoms despite at least 6 months of conservative treatment.
  • Frozen shoulder defined by at least one of the following: forward flexion less than 100 degrees, external rotation less than 60 degrees, internal rotation limited such that the dorsum of the hand could not reach above the L5 vertebral level, or at least a 50% reduction in shoulder motion in any plane compared with the unaffected shoulder.
  • Willingness to provide written informed consent and comply with the study procedures and follow-up schedule.

You may not qualify if:

  • Secondary frozen shoulder.
  • Known allergy to any medication planned for use in the study.
  • Pregnancy or breastfeeding.
  • Severe osteoporosis.
  • Unstable systemic medical condition.
  • Active infection at the planned intervention site.
  • Hemiplegia or hemiparesis affecting the involved extremity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Katip Celebi University Ataturk Training and Research Hospital

Izmir, İzmir, 35360, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Bursitis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized controlled
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 23, 2026

First Posted

July 28, 2026

Study Start

February 24, 2025

Primary Completion

August 25, 2025

Study Completion

September 15, 2025

Last Updated

July 29, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the results reported in the publication will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Access Criteria
Data will be available from the corresponding author upon reasonable request. Requests will be evaluated based on the scientific merit of the proposed research and compliance with applicable ethical and patient privacy requirements. Data will be shared only after appropriate institutional approval and completion of a data-use agreement, where required.

Locations